Dynamic Contrast-enhanced MRI Combined With IVIM-DWI for Early Prediction of Chemosensitivity in Liver MBC

Inclusion Criteria

• •1. The primary lesion was pathologically confirmed to be breast cancer, and the patients diagnosed by two imaging methods or pathologically confirmed to be liver metastasis of breast cancer had at least one liver metastasis with the longest diameter ≥ 10mm;
• •2. No second primary malignant tumor;
• •3. ECOG score, 0-2 ;
• •4. The organ function is normal and can tolerate chemotherapy and other anti-tumor treatments;
• •5. The patient plans to receive systemic chemotherapy or systemic anti-tumor treatment, and the whole process of cooperative treatment. The patient has good compliance with the planned treatment and follow-up, can understand the research process of this study and sign a written informed consent；
• •6. Contraception during the study period and within 6 months after treatment, non lactation period.